drugset / Trial / NCT05556473
F-Tryptophan PET/CT in Human Cancers
Phase 1
Recruiting
24 enrolled
Barbara Ann Karmanos Cancer Institute
Washington University School of Medicine · collab
NaSingle-groupOpen-labelDiagnostic
Summary
Imaging procedures such as 1-(2-\[18F\]FLUOROETHYL)-L-Tryptophan PET/CT in patients with cancers may help doctors assess a patient's response to treatment and help plan the best treatment in the future. The purpose is to see if there can be a better differentiation of tumor and non-tumor tissue where the tumor tissue has a higher uptake of Tryptophan.
Timeline
- Start
- 2022-09-29
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 1-(2-[18F]FLUOROETHYL)-L-Tryptophan | Diagnostic / imaging agent | 5 mbq/kg | Other |